PRETOMANID | PRETOMANID | ATC J04AK08
ANTIINFECTIVES NITROIMIDAZOOXAZINE ANTIMYCOBACTERIAL DRUG TREATMENT OF ADULTS WITH PULMONARY EXTENSIVELY DRUG RESISTANT (XDR) TREATMENT-INTOLERANT OR NONRESPONSIVE MULTIDRUG-RESISTANT (MDR) TUBERCULOSIS (TB) INHIBITING MYCOLIC ACID BIOSYNTHESIS | ORAL | Cmax 5.5 MICROMOLAR Tmax 5 HOUR VD 97 LITER PPB 86.4 PERCENT Cl 3.9 LITER / HOUR HT 17.4 HOUR | | Unknown more at DrugCentral | EMA ANSM (in French) Inxight Drugs Dailymed Drugs.com SIDER side effects Chemical Probes Portal ChEMBL BindingDB DrugBank |